Kirkland Advises PAI Pharma on Acquisition of Nexus Pharmaceuticals
Kirkland & Ellis advised PAI Pharma, a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines and ready-to-use sterile injectable and hospital-focused products, on its acquisition of Nexus Pharmaceuticals, LLC, a pharmaceutical company specializing in the development and commercialization of injectable medicines used in critical care, oncology and other hospital settings.
The Kirkland team included corporate lawyers Matt Goulding, Matt Dunnet, Neil Tiwari and Saabhir Gill; tax lawyers Roger Lucas and Allison Bray; and healthcare transaction lawyers Dennis Williams, William Richmond, Alexa Auger and Annette Rangoussis.








